Screener
Alnylam Pharmaceuticals ALNY Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Alnylam Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Marketable debt securities | 1,599,829 | 1,251,234 |
| Accounts receivable, net | 912,739 | 777,567 |
| Inventory | 97,110 | 82,719 |
| Prepaid expenses and other current assets | 302,176 | 281,892 |
| Total current assets | 4,620,172 | 4,050,662 |
| Property, plant and equipment, net | 554,143 | 513,147 |
| Operating lease right-of-use assets | 183,359 | 194,916 |
| Deferred tax assets | 113,792 | 125,975 |
Cover / Front Matter
FAQ
- What is Alnylam Pharmaceuticals's prepaid & other current?
- Alnylam Pharmaceuticals (ALNY) reported prepaid & other current of $302.18M in Q2 2026.
- How has Alnylam Pharmaceuticals's prepaid & other current changed year-over-year?
- Alnylam Pharmaceuticals's prepaid & other current increased by 105.1% year-over-year, from $147.31M to $302.18M.
- What is the long-term trend for Alnylam Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's prepaid & other current has grown at a 35.0% compound annual growth rate (CAGR), from $62.77M to $281.89M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Alnylam Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude